Last reviewed · How we verify
Zinc supplementation plus standard treatment
At a glance
| Generic name | Zinc supplementation plus standard treatment |
|---|---|
| Sponsor | Muhammad Aamir Latif |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effectiveness of Pulsed Electromagnetic Fields and Nutraceutical Supplementation in Women With Distal Radius Fracture (NA)
- Zinc Plus Saccharomyces Boulardii Versus Zinc Alone in the Treatment of Acute Diarrhea (NA)
- Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition. (NA)
- Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome (NA)
- Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia (PHASE1, PHASE2)
- Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients (NA)
- Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes (PHASE4)
- Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: